5% stakes
Paradigm Biocapital Advisors
Institution
- 5% stake reports
- 36
- 5% stake stocks
- 18
- Latest report
- 26/10/01
5% stake reports
| Stock | ||
|---|---|---|
| Spyre Therapeutics SYRE10/01 | 5.1%4,457,450 sh | First report |
| Tyra Biosciences TYRA09/17 | 5.8%3,473,453 sh | First report |
| Assembly Biosciences ASMB08/14 | 7.8%1,553,748 sh | +2.4pp |
| Viridian Therapeutics, Inc.\DE VRDN08/14 | 6.1%6,723,788 sh | +1.0pp |
| Lexeo Therapeutics LXEO08/14 | 5.3%4,175,382 sh | −3.0pp |
| Edgewise Therapeutics EWTX08/14 | 9.5%10,215,455 sh | +3.3pp |
| Maze Therapeutics MAZE08/14 | 0%0 sh | −6.1pp |
| Jade Biosciences JBIO07/17 | 5.1%3,106,793 sh | First report |
| Viridian Therapeutics, Inc.\DE VRDN06/26 | 5.1%5,633,788 sh | First report |
| MBX Biosciences MBX06/24 | 5.2%2,493,015 sh | First report |
| EyePoint EYPT05/15 | 3.8%3,142,437 sh | −1.3pp |
| UroGen Pharma URGN05/15 | 3.5%1,703,949 sh | −5.5pp |
| Lexeo Therapeutics LXEO05/15 | 8.3%6,184,134 sh | +1.8pp |
| Erasca ERAS05/15 | 3.3%10,392,702 sh | −2.0pp |
| Assembly Biosciences ASMB05/11 | 5.4%865,251 sh | First report |
| Achieve Life Sciences ACHV04/24 | 9.2%9,903,712 sh | First report |
| Maze Therapeutics MAZE04/01 | 6.1%3,051,087 sh | First report |
| EyePoint EYPT02/24 | 5.1%4,192,261 sh | First report |
| Edgewise Therapeutics EWTX02/17 | 6.2%6,541,210 sh | +1.2pp |
| Vor Biopharma VOR02/17 | 4.5%1,750,000 sh | −4.1pp |
